Disclosed the monthly exercise status for August 2026 as of today. Number of shares issued for stock acquisition rights: 80,000 shares; number of exercised rights: 800 units; exercise rate: 4.41%; unexercised: total 8,000 units; issued shares: 9,030,000 shares (including 289,868 shares of treasury stock).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4840","jir_company_name":"Tria Eyes Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4840-20260901-01.pdf","jir_short_summary":"Disclosed the monthly exercise status for August 2026 as of today. Number of shares issued for stock acquisition rights: 80,000 shares; number of exercised rights: 800 units; exercise rate: 4.41%; unexercised: total 8,000 units; issued shares: 9,030,000 shares (including 289,868 shares of treasury stock).","jir_summary":"### IR Section Overview\nThis report condenses the monthly exercise status of the 17th stock acquisition rights (with exercise price adjustment clause) as of August 2026. For the targeted month, the number of issued shares is 80,000; rights actually exercised are 800 units, with 671 new shares; transferred treasury shares are 0. The total issued is 18,100 units, with unexercised shares at the end of the prior month 8,800 and at the end of the month 8,000. Compliance with exercise restrictions is reported at 0.96% based on the listing regulations.\n\n### Impact on shareholders and Outlook\nThe monthly exercise status overall remains modest, and the impact on the total outstanding shares is expected to be small. In future monthly reports, continued exercise trends and treasury stock holdings will be key points. Note that prior disclosed information refers to the third-party allocation announced on February 25, 2026, relating to the 17th stock acquisition rights offering, and future exercise movements will be a focal point of IR.","jir_financial_highlights":"Shares issued for the targeted month (shares): 80,000 (Unknown)\nNumber of stock acquisition rights exercised in the targeted month: 800 (Unknown)\nTotal number of stock acquisition rights issued: 18,100 (Unknown)\nExercise ratio: 0.96\uff05 (Unknown)","jir_category":"","jir_hashtags":"#TriaEyes_IR","jir_key_figures":"80,000: Shares issued for the targeted month (shares)\n800: Number of stock acquisition rights exercised in the targeted month\n0.96\uff05: Exercise rate","jir_meta_title":"\u3010Tria Eyes Co., Ltd.\u3011Notice of Monthly Exercise Status of Stock Acquisition Rights\uff5cAugust 2026","jir_meta_description":"Tria Eyes Co., Ltd. announces the August monthly exercise status of the 17th stock acquisition rights. 80,000 shares issued, 800 exercised, 0.96% exercise rate, 8,000 unexercised. Please note future developments.","jir_og_title":"\u3010Tria Eyes Co., Ltd.\u3011Notice of Monthly Exercise Status of Stock Acquisition Rights\uff5cAugust 2026","jir_og_description":"Summary of August exercise status for Tria Eyes stock acquisition rights. 80,000 shares issued, 800 exercised, 0.96% exercise rate, 8,000 unexercised.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60349,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-109566","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n